Osteoporosis, Postmenopausal
Showing 1 - 25 of 3,048
Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)
Recruiting
- Osteoporosis, Postmenopausal
- Denosumab
-
Yantai, Shandong, ChinaShandong Boan Biotechnology Co., Ltd.
May 2, 2023
Osteoporosis, Postmenopausal Trial (early versus late biopsy)
Not yet recruiting
- Osteoporosis, Postmenopausal
- early versus late biopsy
- (no location specified)
Jan 9, 2023
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Cohort follow-up)
Recruiting
- Osteoporosis, Postmenopausal
- Cohort follow-up
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Oct 6, 2022
Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)
Completed
- Hypovitaminosis D
- +2 more
-
Mexico City, Gustavo A. Madero, MexicoPatricia Loranca-Moreno
Jan 24, 2023
Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)
Active, not recruiting
- Osteoporosis, Postmenopausal
- TVB-009
- Prolia®
-
Port Saint Lucie, FloridaSite 10101
Feb 1, 2023
Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)
Not yet recruiting
- Osteoporosis, Postmenopausal
- Zoledronate
- Placebo
- (no location specified)
Dec 15, 2022
Osteoporosis, Postmenopausal Trial (AVT03 (denosumab))
Recruiting
- Osteoporosis, Postmenopausal
- denosumab
-
Port Elizabeth, Gqeberha, South AfricaPHOENIX Pharma(Pty)Ltd
Sep 1, 2022
Menopause Related Conditions, Sarcopenia, Osteoporosis Postmenopausal Trial in Pamplona (Time Restricted Eating (TRE), Exercise,
Recruiting
- Menopause Related Conditions
- +3 more
- Time Restricted Eating (TRE)
- +2 more
-
Pamplona, Navarra, SpainUniversidad Pública de Navarra
Jun 12, 2023
Postmenopausal Osteoporosis Trial in Boston (Romosozumab, Denosumab)
Recruiting
- Postmenopausal Osteoporosis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2022
Postmenopausal Osteoporosis Trial in Beijing (Minodronate, Alendronate)
Not yet recruiting
- Postmenopausal Osteoporosis
-
Beijing, Beijing, ChinaPeking University Third Hospital
Dec 8, 2022
Postmenopausal Osteoporosis Trial in Seoul (Risedronate Sodium 35 MG [Actonel], Calcium Vitamin D combination)
Not yet recruiting
- Postmenopausal Osteoporosis
- Risedronate Sodium 35 MG [Actonel]
- Calcium Vitamin D combination
-
Seoul, Seodaemun-gu, Korea, Republic ofSeverance Hospital
Nov 29, 2022
Postmenopausal Osteoporosis Trial in Cairo (device, behavioral, dietary supplement)
Not yet recruiting
- Postmenopausal Osteoporosis
- Ultraviolet Radiation
- +2 more
-
Cairo, EgyptKasr Alainy medical school
Dec 6, 2022
Osteopenia, Osteoporosis, Postmenopausal Osteoporosis Trial in Birmingham (Exercise training)
Not yet recruiting
- Osteopenia
- +3 more
- Exercise training
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 16, 2022
Osteoporosis, Postmenopausal Trial in Cairo (Calcium carbonate, Vitamin D3, laser acupuncture therapy)
Completed
- Osteoporosis, Postmenopausal
- Calcium carbonate
- +2 more
-
Cairo, EgyptKasr Alainy medical school
Sep 26, 2022
Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With
Completed
- Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis
- exercises
-
Belgrade, SerbiaTamara Filipovic
Nov 14, 2022
Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)
Not yet recruiting
- Nonalcoholic Fatty Liver
- Osteoporosis, Postmenopausal
- Denosumab
- Alendronate Sodium
- (no location specified)
Aug 6, 2022
Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures Trial in Pittsburgh (denosumab, Placebo, Calcium and Vitamin
Active, not recruiting
- Osteoporosis, Postmenopausal
- +2 more
- denosumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Senior Communities
Sep 7, 2022
Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture Trial in Pittsburgh (Romosozumab, Placebo, Zoledronic acid)
Recruiting
- Osteoporosis
- +2 more
- Romosozumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Senior Communities
Sep 7, 2022
Postmenopausal Osteoporosis Trial in Changchun (JMT103, Denosumab, Placebo)
Recruiting
- Postmenopausal Osteoporosis
- JMT103
- +2 more
-
Changchun, Jilin, ChinaThe Second Hospital of Jilin University
Jul 14, 2022
Osteoporosis, Osteoporosis, Postmenopausal Trial in Sant Cugat Del Vallès (Focal Vibration, Control Group)
Not yet recruiting
- Osteoporosis
- Osteoporosis, Postmenopausal
- Focal Vibration
- Control Group
-
Sant Cugat Del Vallès, Barcelona, SpainUniversitat Internacional de Catalunya
Sep 13, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without
Recruiting
- Osteoporosis, Postmenopausal
- Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
- Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2022
Primary Hyperparathyroidism, Osteoporosis, Postmenopausal Trial in Philadelphia
Active, not recruiting
- Primary Hyperparathyroidism
- Osteoporosis, Postmenopausal
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine/ Hospital of the Universit
Sep 22, 2022
Cortical Bone Mechanics Technology Fracture Discrimination
Recruiting
- Osteoporosis
- +6 more
- Cortical Bone Mechanics Technology
-
Gainesville, Florida
- +4 more
Feb 7, 2023
Osteoporosis, Postmenopausal Trial in Jaipur (Denosumab, Denosumab-Ref)
Recruiting
- Osteoporosis, Postmenopausal
-
Jaipur, Rajasthan, IndiaS. R. Kalla Memorial Gastro & General Hospital
Aug 16, 2022